Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 239-622-4 | CAS number: 15571-58-1
Endpoint summary
Administrative data
Description of key information
-Acute oral: several studies are available. The study of 1992 was choosen as key study because DOTE with a purity of 90% was used in this study (the others studies "klimisch 2" used DOTE with a purity smaller than 90% or DOTC).
-Acute dermal : two key studies were available.
-No information on acute inhalation toxicity was available.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
Acute toxicity: via dermal route
Endpoint conclusion
- Dose descriptor:
- discriminating dose
- Value:
- 2 000 mg/kg bw
Additional information
Acute oral :
A robust acute oral toxicity rat study (OECD guideline 401) was carried out with a mixture of DOT (2 -EHMA) and MOT(2 -EHMA) (90:10%). Two doses of 1000 and 2000 mg/kg bw were tested (single dose) with a 14 -days observation period. Animals in both dose groups exhibited clinical signs of toxicity and effects on mortality were observed. The LD50 was lower than 2000 mg/kg for female rats, the overall LD50 for males and females was 2000 mg/kg bw (lower 95% confidence limit= 1265 mg/kg/bw) ('Acute toxicity category 4' / H302, harmful if swallowed according to GHS).
Acute dermal :
A robust acute dermal toxicity rat study (OECD guideline 402) was carried out with a mixture of DOT(2 -EHMA) and Octyltin tris(2-EHMA) (90:10 % w/w).The test dose was 2000 mg/kg bw; the dose volume applied was 2 ml/kg bw. After 24 hours, the exposed skin was cleaned and the area of application was observed for 14 days. Due to the lack of observed mortality, the 14-day acute dermal LD50s of the test substance were reported as: LD50 (both sexes) >2000 mg/kg bw.
An other study was carried out with a mixture of DOT (2 -EHMA) and MOT(2 -EHMA) (70:30%), the same result is observed : LD50 > 2000 mg/kg bw.
Acute inhalation : no study
Justification for classification or non-classification
Acute oral :
Based on the observed oral LD50 value, DOT(2 -EHMA) is classified with R22 according to Directive 67/548/EEC and 'Acute toxicity category 4' (H302, harmful if swallowed) according to Regulation EC No.1272/2008 (CLP). Justification : LD50 = 2000 mg/kg bw.
Acute dermal :
Based on the acute dermal toxicity study, classification is not warranted according to Directive 67/548/EEC and Regulation EC No.1272/2008 (CLP).
Justification : LD50> 2000 mg/kg bw.
Acute Inhalation : not classified be because no study
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
